Key Concepts in Biodefense Vaccines

• FDA

  • Animal rule regarding efficacy
  • All other requirements remain
  • Priority review
  • Emergency Use Authorization (BioShield)

• NIH participation in product development

  • Active collaboration / coordination
  • Funding through grants and contracts

• Satisfying multiple government agencies

• Contracts focus on product development

• Grants encourage exploratory research

Previous slide

Next slide

Back to first slide

View graphic version